Prothena Plc Company Insiders

PRTA Stock  USD 14.53  0.75  5.44%   
Prothena Plc's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Prothena plc suggests that vertually all insiders are panicking. Prothena Plc employs about 173 people. The company is managed by 14 executives with a total tenure of roughly 23 years, averaging almost 1.0 years of service per executive, having 12.36 employees per reported executive.
Wagner Zago  Executive
Chief Scientific Officer
Carol Karp  Executive
Chief Regulatory Officer

Prothena Plc's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-01-24Karin L. WalkerDisposed 5000 @ 34View
2023-12-20Karin L. WalkerDisposed 5000 @ 37.19View
Monitoring Prothena Plc's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

Prothena Plc's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Prothena Plc's future performance. Based on our forecasts, it is anticipated that Prothena will maintain a workforce of about 170 employees by January 2025.
 
Yuan Drop
 
Covid

Prothena Plc Management Team Effectiveness

The company has return on total asset (ROA) of (0.1566) % which means that it has lost $0.1566 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.229) %, meaning that it created substantial loss on money invested by shareholders. Prothena Plc's management efficiency ratios could be used to measure how well Prothena Plc manages its routine affairs as well as how well it operates its assets and liabilities. As of December 4, 2024, Return On Tangible Assets is expected to decline to -0.22. The current year's Return On Capital Employed is expected to grow to -0.28. At present, Prothena Plc's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 16.1 M, whereas Total Assets are forecasted to decline to about 414.8 M.
As of December 4, 2024, Common Stock Shares Outstanding is expected to decline to about 35.1 M. In addition to that, Net Loss is expected to decline to about (110.5 M)

Prothena Plc Workforce Comparison

Prothena plc is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 2,996. Prothena Plc holds roughly 173 in number of employees claiming about 6% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.99) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (68.57) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $68.57.

Prothena Plc Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Prothena Plc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Prothena Plc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Prothena Plc insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-03-01
5.5
11
2
 1,093,000 
 10,000 
2023-12-01
0.3333
5
15
 24,000 
 48,000 
2023-09-01
0.3333
18
54
 76,000 
 152,000 
2023-06-01
0.4407
26
59
 376,333 
 482,666 
2023-03-01
0.5294
18
34
 588,834 
 215,668 
2022-12-01
0.2564
20
78
 239,500 
 454,280 
2022-09-01
0.3889
14
36
 194,662 
 399,246 
2022-06-01
1.5
15
10
 1,252,736 
 1,092,736 
2022-03-01
4.0
12
3
 1,165,500 
 5,000 
2021-12-01
0.2667
8
30
 72,519 
 145,038 
2021-09-01
0.3824
13
34
 146,676 
 99,646 
2021-06-01
1.5
15
10
 774,250 
 245,000 
2021-03-01
1.4146
58
41
 3,310,222 
 1,434,200 
2020-09-01
1.0
1
1
 10,000 
 10,000 
2018-12-01
0.5
1
2
 35,000 
 130,000 
2017-12-01
0.3333
1
3
 3,500 
 7,000 
2017-09-01
0.4348
10
23
 54,600 
 109,200 
2017-06-01
0.8462
11
13
 200,500 
 123,000 
2017-03-01
0.8235
14
17
 374,709 
 97,418 
2016-12-01
0.5294
9
17
 172,292 
 84,584 
2016-09-01
0.4615
6
13
 79,500 
 59,000 
2016-06-01
1.0
12
12
 104,000 
 27,820 
2016-03-01
1.1
11
10
 592,125 
 14,250 
2015-12-01
0.3143
11
35
 182,916 
 359,166 
2015-09-01
0.3235
11
34
 109,916 
 209,833 
2015-06-01
1.1429
8
7
 120,125 
 30,250 
2015-03-01
1.6667
10
6
 443,625 
 37,250 
2014-12-01
0.5
3
6
 7,500 
 15,000 
2014-09-01
1.0
2
2
 4,500 
 5,000 
2014-06-01
4.0
8
2
 147,356 
 16,000 
2014-03-01
7.0
7
1
 402,000 
 3,182,253 
2013-09-01
1.0
1
1
 50,000 
 0.00 

Prothena Plc Notable Stakeholders

A Prothena Plc stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Prothena Plc often face trade-offs trying to please all of them. Prothena Plc's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Prothena Plc's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Hideki MDChief OfficerProfile
CPA CPAChief ControllerProfile
Jennifer ZibudaDirector CommunicationProfile
Brandon SmithChief OfficerProfile
Wagner ZagoChief Scientific OfficerProfile
Carol KarpChief Regulatory OfficerProfile
David FordChief OfficerProfile
Chad SwansonChief OfficerProfile
Yvonne TchrakianCompany SecretaryProfile
Michael MalecekChief SecretaryProfile
Mark CFAVice RelationsProfile
Karin CPAChief ControllerProfile
Tran MBACFO OfficerProfile
Gene KinneyChief Scientific Officer and Head of RandDProfile

About Prothena Plc Management Performance

The success or failure of an entity such as Prothena plc often depends on how effective the management is. Prothena Plc management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Prothena management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Prothena management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.21)(0.22)
Return On Capital Employed(0.30)(0.28)
Return On Assets(0.21)(0.22)
Return On Equity(0.26)(0.25)
Please note, the presentation of Prothena Plc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Prothena Plc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Prothena Plc's management manipulating its earnings.

Prothena Plc Workforce Analysis

Traditionally, organizations such as Prothena Plc use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Prothena Plc within its industry.

Prothena Plc Manpower Efficiency

Return on Prothena Plc Manpower

Revenue Per Employee528.2K
Revenue Per Executive6.5M
Net Loss Per Employee849.9K
Net Loss Per Executive10.5M
Working Capital Per Employee3.4M
Working Capital Per Executive41.6M

Complementary Tools for Prothena Stock analysis

When running Prothena Plc's price analysis, check to measure Prothena Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prothena Plc is operating at the current time. Most of Prothena Plc's value examination focuses on studying past and present price action to predict the probability of Prothena Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prothena Plc's price. Additionally, you may evaluate how the addition of Prothena Plc to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data